|
|
 |
 |
 |
 |
 |
 |
|
|
Albert B. Sabin Vaccine Institute
The Sabin Vaccine Institute is an independent, nonprofit vaccine think tank based at Georgetown University in Washington DC. The Sabin Institute has supported four of the symposia in the HIV Vaccines for Developing Countries series: Designing Efficacy Trials held in Boston, Massachusetts in October 1996; DNA Vaccines, New Adjuvants, and Novel Delivery Systems held in Boston, in April 1997; Immune Correlates of Protection held in Boston, in April 1998; and Prioritizing Vaccine Candidates for Human Trials held in October 1999. For more information, visit http://www.sabin.org.
Until There’s a Cure Foundation
Founded in 1993, Until There’s a Cure is a nonprofit foundation founded to raise money for care services and foster compassion for those infected with HIV; to provide prevention education; and to advocate vaccine development to eradicate the HIV virus. Until There’s a Cure Foundation has co-sponsored five of the symposia of the HIV Vaccines for Developing Countries series. UTAC provided support for Designing Efficacy Trials held in Boston, Massachusetts in October 1996; DNA Vaccines, New Adjuvants, and Novel Delivery Systems held in Boston, in April 1997; Immune Correlates of Protection held in Boston, in April 1998; Vaccinating Against the Leading Infectious Killers of Children held in Dakar, Senegal in December 1998; and Subtype C held in Arusha, Tanzania in December 2000. For more information, visit http://www.utac.org.
United States Centers of Disease Control and Prevention
The United States Centers of Disease Control and Prevention (CDC) is a federal agency that serves as the national focus for developing and applying disease prevention and control, environmental health, and health promotion and education activities designed to improve the health of the people of the United States.
In Botswana, HAI collaborates with the CDC through the BOTUSA Project and the KITSO AIDS Training Program. Established in 1995, the BOTUSA Project is a collaborative effort between the Botswana Ministry of Health, the United States Centers for Disease Control and Prevention, Division of Tuberculosis Elimination, and the Global AIDS Program. The principal goal of the BOTUSA Project is to expand knowledge of the relationship between epidemic tuberculosis and epidemic HIV disease in a resource-poor country setting so that this information can be used to develop prevention strategies for the local and global control of TB. BOTUSA staff works closely with counterparts in the Botswana National TB Programme and AIDS Control Programme. For more information, visit http://www.cdc.gov.
United States Department of State
The United States Department of State collaborates with HAI through the China Initiative. The State Department invited Principal Research Scientist Yichen Lu to travel to China in November 2001 for a six-city speaking tour that included lectures, meetings, and consultations with university researchers, students, public health officials, and local news media. Through the United States Consulate in Shanghai, the State Department engaged HAI’s China Initiative to conduct videoconferences between clinicians treating people living with HIV and AIDS in China and HIV and AIDS care experts at Harvard University in order to share new advances in the field of HIV medicine.
United States Health Resources and Services Administration HIV/AIDS Bureau
The HIV/AIDS Bureau of the U.S. Health Resources and Services Administration, an agency of the Department of Health and Human Services, administers the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act. The HIV/AIDS Bureau provides support for the Enhancing Care Initiative in western Puerto Rico. For more information, visit http://www.hrsa.gov. For more information on the Enhancing Care Initiative, visit http://www.eci.harvard.edu.
United States Military HIV Research Program
The mission of the U.S. Military HIV Research Program is to prepare and protect military forces deployed for peacekeeping missions. It has built upon over a century of military medical successes, vaccine development and innovative therapeutic interventions for infectious diseases. The program has been a long-term research collaborator and principal sponsor of HAI’s HIV Vaccines for Developing Countries series. The program provided sponsorship for the following symposia. DNA Vaccines, New Adjuvants, and Novel Delivery Systems, held Boston, Massachusetts, in April 1997; Immune Correlates of Protection, held in Boston, in April 1998; Vaccinating Against the Leading Infectious Killers of Children, held in Dakar, Senegal in December 1998; Prioritizing Vaccine Candidates for Human Trails, held in Boston, in October 1999; and Establishing Networks for HIV Vaccine Trials in Southern Africa, held in Gaborone, Botswana, in December 2001. For more information, visit http://www.hivresearch.org.
University of Botswana
A strong educational presence in Botswana and throughout Southern Africa, the University of Botswana is a comprehensive university with quality undergraduate programs and growing graduate education. The Botswana–Harvard AIDS Institute Partnership for Research and Education collaborates with the University of Botswana in HIV and AIDS education and research. Committed to teaching, learning, and generating research through the discovery, integration, dissemination, and application of knowledge, the University of Botswana is advancing the intellectual and human resource capacity of the nation of Botswana and the international community. For more information, visit http://www.ub.bw.
Universite Cheikh Anta Diop
Since 1985, HAI has collaborated with researchers at the Universite Cheikh Anta Diop in Dakar, Senegal on HIV research, including the longest standing AIDS study in Africa. Joint research with Universite Cheikh Anta Diop resulted in the discovery of HIV-2, the second human AIDS virus, and this ongoing collaboration continues to be a fruitful partnership for research and discovery.
The Harvard AIDS Institute also collaborates with Universite Cheikh Anta Diop through the Enhancing Care Initiative. Faculty members from the Department of Medicine work together with other local AIDS care experts on the Initiative’s multi-disciplinary AIDS care team in Senegal. For more information on the Enhancing Care Initiative, visit http://www.eci.harvard.edu.
University of Natal, Nelson R. Mandela School of Medicine
The Harvard AIDS Institute collaborates with the University of Natal in Durban, South Africa through the Enhancing Care Initiative. Faculty members from the Nelson R. Mandela School of Medicine’s Department of Medicine and Department of Community Health work together with other local AIDS care experts on the Initiative’s multi-disciplinary AIDS care team in South Africa. For more information, visit http://www.nu.ac.za/department/default.asp?dept=medicineund. For more information on the Enhancing Care Initiative, visit http://www.eci.harvard.edu.
University of Puerto Rico - Mayaguez
The Harvard AIDS Institute collaborates with the University of Puerto Rico in Mayaguez, Puerto Rico through the Enhancing Care Initiative. Faculty members from the Social Sciences Department and Philosophy Department work together with other local AIDS care experts on the Initiative’s multi-disciplinary AIDS care team in Puerto Rico. For more information, visit http://www.uprm.edu. For more information on the Enhancing Care Initiative, visit http://www.eci.harvard.edu.
University of Sao Jose do Rio Preto
The Harvard AIDS Institute collaborates with University of Sao Jose do Rio Preto through the Enhancing Care Initiative. Faculty members from the School of Medicine work together with other local AIDS care experts on the Initiative’s multi-disciplinary AIDS care team in Brazil. For more information, visit http://www.eci.harvard.edu/.
University of Sao Paulo
The Harvard AIDS Institute collaborates with the University of Sao Paulo through the Enhancing Care Initiative. Faculty members from the School of Medicine, School of Public Health, and School of Psychology work together with other local AIDS care experts on the Initiative’s multi-disciplinary AIDS care team in Brazil. For more information, visit http://www2.usp.br/. For more information on the Enhancing Care Initiative, visit http://www.eci.harvard.edu/.
The Wellcome Trust
The Wellcome Trust is an independent research-funding charity organization, established in 1936. The Trust provided support for the International Symposium on HIV, Leukemia, and Opportunistic Cancers that took place in Marrakech, Morocco in May 1999. For more information, visit http://www.wellcome.ac.uk.
Wyeth-Lederle Vaccines
Wyeth-Lederle is a pharmaceutical producer of vaccines in North America. The company provided support for two symposia of HAI’s HIV Vaccines for Developing Countries series: Prioritizing Vaccine Candidates for Human Trials held in Boston, Massachusetts in October 1999 and Establishing Networks for HIV Vaccine Trials in Southern Africa held in Gaborone, Botswana in December 2001. For more information, visit http://www.vaccineworld.com.
|
|
|
